Northwind Pharmaceuticals

Why Buy-In from the Top-Down Again and Again is Important

Why-Buy-In-from-the-Top-Down-Again-and-Again-is-ImportantHospitals and other Healthcare organizations that are trying to stay ahead of the advances that technology is delivering are focusing a lot on collaboration and total team approach. In a recent article published by HealthITNews, directors talk about a few key factors to ensuring success as administration meet together to discuss how to integrate technology in its solutions.

How to Get the Total Team Approach

  1. Be Part of the Solution: C-level executives sometimes rely on their stakeholders and subject matter experts to drive conversation when it comes to making key decisions. A total team approach means not only listening to important ideas but starting the conversations.
  2. Be a Good Listener: Listen to what your employees are saying and address concerns by acknowledging them.
  3. Resist the Superman Approach: It’s easy to fall into the trap of being the “Superman” in a situation. Today’s environment is changing. It doesn’t work to take the role of the hero in the healthcare setting when it comes to decisions that impact everyone from the top down.

The fact is that if your organization wants to be known as a healthcare organization that is cutting edge, you will have to be cutting edge and adopt cutting edge solutions and practices. One way to up the ante is to add physician dispensing to your organization.

With a simplicity that employees love, efficiency that they crave and a “why didn’t we do this a long time ago?” level of satisfaction, in-house dispensing can keep your organization on top. Let Northwind Pharmaceuticals help you achieve your goals now and in 2015!

Schedule a free claims analysis now.

Let’s Talk now

Healthcare Storm 2025: What Will It Be?

Phillip Berry | Jan 1st, 2025
When it comes to American healthcare, we’ve become really good at highlighting its failings. Watching the flurry of lamentations, frustrations, denigrations, and prognostications, over the last few weeks, would lead any rational person to believe that nothing is working in our healthcare system. And, not only is it “not working,” many people conclude that it … more »

continue reading

New Drugs to Market – October Update

Phillip Berry | Oct 25th, 2024
The Food and Drug Administration (FDA) approved three novel drug therapies in October. One of those therapies,  Hympavzi (marstacimab-hncq), is a medication indicated for the treatment of patients with Hemophilia A and Hemophilia B. Hympavzi utilizes a new pathway to help reduce the risk of bleeding episodes in patients with Hemophilia, a disease that impacts … more »

continue reading

Letter From a Pharmacist – On Pharmacy Closures

Phillip Berry | Oct 25th, 2024
Pharmacists have a time-honored role as an integral contributor to the delivery of health care. From the earliest apothecaries to the retail stores of today, community pharmacists have provided guidance about health, wellness and medication therapy. Their expertise ranges from preventive care to the most advanced medications used in the treatment of complex disease.  Despite … more »

continue reading